Advertisement
Singapore markets open in 4 hours 16 minutes

  • Straits Times Index

    3,367.90
    +29.33 (+0.88%)
     

  • S&P 500

    5,509.01
    +33.92 (+0.62%)
     

  • Dow

    39,331.85
    +162.33 (+0.41%)
     

  • Nasdaq

    18,028.76
    +149.46 (+0.84%)
     

  • Bitcoin USD

    61,937.12
    -1,298.24 (-2.05%)
     

  • CMC Crypto 200

    1,333.24
    -11.27 (-0.84%)
     

  • FTSE 100

    8,121.20
    -45.56 (-0.56%)
     

  • Gold

    2,338.90
    0.00 (0.00%)
     

  • Crude Oil

    83.19
    -0.19 (-0.23%)
     

  • 10-Yr Bond

    4.4360
    -0.0430 (-0.96%)
     

  • Nikkei

    40,074.69
    +443.63 (+1.12%)
     

  • Hang Seng

    17,769.14
    +50.53 (+0.29%)
     

  • FTSE Bursa Malaysia

    1,597.96
    -0.24 (-0.02%)
     

  • Jakarta Composite Index

    7,125.14
    -7,139.63 (-50.05%)
     

  • PSE Index

    6,358.96
    -39.81 (-0.62%)
     

EU extends decision date on Novoyzmes, Chr. Hansen deal to Dec. 12

Reuters
·1-min read
Biotechnology company Chr. Hansen, in Avedoere

BRUSSELS (Reuters) - EU antitrust regulators have extended their date for a decision on the tie-up of Danish food ingredients and enzymes makers Novozymes and Chr. Hansen to Dec. 12 after the companies offered remedies to address competition concerns.

Novozyme, which makes enzymes for household products, food and beverages and biofuels, and Chr. Hansen, enzyme maker for the food sector, proposed on Monday to sell part of the combined company's global lactase enzyme business. A buyer has already been found.

The EU competition watchdog will now seek feedback from customers and rivals of the companies before deciding whether to accept the offer, demand more or open a full-scale investigation.

The companies expect to close the deal in the last quarter of the year or the first quarter of 2024. Antitrust authorities in China, Brazil, Turkey and the United States have already given the green light to the merger.

(Reporting by Foo Yun Chee, Editing by Louise Heavens)